09 April 2024
Top hires for VC & PE portfolio companies Q1-2024
Search Highlights
Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
This quarter’s successful placements include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Therapeutic devices | Austria |
| Chief Business Officer | Precision biologics | US |
| Chief Financial Officer | Remote monitoring | France |
| Chief Strategy Officer | Medical devices | Israel |
| Chief Medical Officer | Radiopharmaceuticals | US |
| Chief of Staff | Vaccines | Denmark |
| VP Global Program Leader, Respiratory | Multi-modality biotech | UK |
| VP Technology & Product Development | DNA technology | UK |
| Controller | Contract manufacturing | US |
| Senior Director Pharmaceutical Development | Drug delivery | Ireland |
| Director Market Access & Pricing Global | Ophthalmology | Italy |
| Investment Manager Digital Health | Life sciences investor | Netherlands |
| General Manager Infectious Diseases | Biocluster | France |
| Board Director | Personalized digital health | Switzerland |
| Board Director | Electronic medical instrumentation | US |
| Board Director | Immunotherapies | Sweden |
Newly opened projects include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Medical devices | Belgium |
| CEO | Precision medicines | US |
| Chief Commercial Officer | Contract research organization (CRO) | UK |
| Chief Development Officer | Protein degradation | DACH |
| Chief Scientific Officer | Small molecules | Spain |
| Chief Financial Officer | Gene therapy | US |
| Chief Operating Officer | Incubator/ tech transfer | UK |
| Head of Strategy & Commercial Excellence | Drug delivery systems | Germany |
| SVP, Head of Business Development | Drug discovery services | Germany |
| VP of Science | Precision nutrition | UK |
| VP, Head of Translational Development | Gene editing | Spain |
| VP Research & Preclinical | Synthetic biology | UK |
| VP Business Development | tRNA technologies | US |
| Life Sciences Partner | Life sciences investor | Italy |
| Board Director | T-cell therapies | US/ Europe |
Related
-
Events
AESC Global Summit on Leadership
17 November 2025 – 18 November 2025
-
Company News
LSX World Congress conference with Justine McIlroy, Client Partner
12 May 2023
-
Thought Leadership
Five Shifts to Digital Personalized Healthcare
10 May 2023
-
Company News
Digital Health UK CEO and Commercial Leaders Breakfast
28 March 2023
